Cargando…
Development and Implementation of Proton Therapy for Hodgkin Lymphoma: Challenges and Perspectives
SIMPLE SUMMARY: Hodgkin lymphoma (HL) is a highly curable disease; proton therapy for mediastinal HL irradiation might theoretically reduce late toxicities compared with classical radiotherapy techniques. However, optimal patient selection for this technique is subject to debate. While implementatio...
Autores principales: | Loap, Pierre, De Marzi, Ludovic, Mirandola, Alfredo, Dendale, Remi, Iannalfi, Alberto, Vitolo, Viviana, Barcellini, Amelia, Filippi, Andrea Riccardo, Jereczek-Fossa, Barbara Alicja, Kirova, Youlia, Orlandi, Ester |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8345082/ https://www.ncbi.nlm.nih.gov/pubmed/34359644 http://dx.doi.org/10.3390/cancers13153744 |
Ejemplares similares
-
Current Situation of Proton Therapy for Hodgkin Lymphoma: From Expectations to Evidence
por: Loap, Pierre, et al.
Publicado: (2021) -
Hadrontherapy for Thymic Epithelial Tumors: Implementation in Clinical Practice
por: Loap, Pierre, et al.
Publicado: (2021) -
Biological Rationale and Clinical Evidence of Carbon Ion Radiation Therapy for Adenoid Cystic Carcinoma: A Narrative Review
por: Loap, Pierre, et al.
Publicado: (2021) -
PARP Inhibitors in Combination with Radiotherapy: To Do or Not to Do?
por: Barcellini, Amelia, et al.
Publicado: (2021) -
Fast Neutron Therapy for Breast Cancer Treatment: An Effective Technique Sinking into Oblivion
por: Loap, Pierre, et al.
Publicado: (2020)